13F Data
13F filer · CIK 1634557

Woodford Investment Management Ltd

London, X0 · filing since Q4 2014 · last filing Jan 27, 2020
Reported value
$2.7B
+$306.9M vs prior
Positions
7
New / sold out
0 / 0
Added / reduced
6 / 1
Turnover
0.1%
buys $210.4M · sells $2.2M
Top-10 weight
100.0%

Biggest buys vs Q1 2017

ChangeSecurityShares changeChange %Est. trade value
AddedBIOVERATIV INC+1,186,500+149.9%+$71.4M
AddedABBVIE INC+937,500+8.6%+$68.0M
AddedGILEAD SCIENCES INC+632,000+39.8%+$44.7M
AddedPROTHENA CORP PLC+294,213+2.6%+$15.9M
AddedALKERMES PLC+177,449+2.4%+$10.3M
AddedTHERAVANCE BIOPHARMA INC+1,072+0.0%+$42.7K

Biggest sells vs Q1 2017

ChangeSecurityShares changeChange %Est. trade value
ReducedBIOGEN INC-8,143-2.2%$-2.2M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $466.1MQ1 2015: $704.3MQ2 2015: $1.3BQ3 2015: $1.7BQ4 2015: $2.3BQ1 2016: $2.2BQ2 2016: $2.1BQ3 2016: $2.5BQ4 2016: $2.1BQ1 2017: $2.4BQ2 2017: $2.7BQ3 2017: $2.2BQ4 2017: $1.5BQ1 2018: $1.1BQ2 2018: $824.7MQ3 2018: $1.3BQ4 2018: $1.2BQ1 2019: $1.2BQ2 2019: $591.2MQ3 2019: $310.1MQ4 2019: $0
Q4 2014Q4 2019

Holdings · Q2 2017

#SecuritySharesValueWeight
1ABBVIE INCCOMMON11,854,758$859.6M31.57%
2PROTHENA CORP PLCSHS11,400,424$617.0M22.66%
3ALKERMES PLCSHS7,647,977$443.4M16.28%
4THERAVANCE BIOPHARMA INCCOMMON10,706,180$426.5M15.67%
5GILEAD SCIENCES INCCOMMON2,220,100$157.1M5.77%
6BIOVERATIV INCCOMMON1,977,764$119.0M4.37%
7BIOGEN INCCOMMON368,645$100.0M3.67%